28.04.2010 • News

Dow Chemical Profit, Revenue Spike

Dow Chemical posted a better-than-expected first-quarter profit on Wednesday as pricing, volume and sales spiked.

Net income rose to $466 million, or 41 cents per share, from $24 million, or 3 cents per share, a year earlier.

Excluding costs related to the 2009 acquisition of rival Rohm & Haas and restructuring, Dow earned 43 cents per share. By that measure, analysts expected earnings of 30 cents, according to Thomson Reuters I/B/E/S. Revenue rose 48.4% to $13.42 billion. Analysts expected $12.93 billion. Midland, Mich.-based Dow bought rival Rohm & Haas last April in a deal that sharply leveraged its balance sheet. Since then, the company has been selling off assets to repay the loan.

Dow peer DuPont said on Tuesday that first-quarter profit more than doubled.

Company

The Dow Chemical Company

100 Larkin Center
48674 Midland

Company contact







Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.